Valvular heart diseases (VHD) are common in the elderly population and several therapeutic options are available to treat them. When selecting the management strategy for VHD patients, to evaluate the operatory risk, using special scores like STS score, EuroSCORE II and other more specific ones is pivotal. However, the risk scores do not consider some aspects, such as the clinical needs of the single patients, the management of local resources and the expertise of the center. The Heart Team, combining the experience of various specialists, can optimize the decision-making process through a better evaluation of the risk/benefit ratio of the therapeutic choices. The multidisciplinary discussion of the most complex cases is recommended by the international guidelines for the management of VHD and it is part of the clinical practice of many centers. So far, both trials and large clinical studies supporting such multidisciplinary management are lacking. Despite these important limitations, the Heart Team can be actually regarded as a promising tool to locally promote best practices for the treatment of VHD patients.
Malara, S., Burzotta, F., Romagnoli, E., Aurigemma, C., Bruno, P., Pavone, N., Graziani, F., Trani, C., Crea, F., Massetti, M., Heart Team e malattie valvolari: L’importanza di un approccio multidisciplinare, <<GIORNALE ITALIANO DI CARDIOLOGIA>>, 2021; 22 (7): 561-569. [doi:10.1714/3629.36107] [http://hdl.handle.net/10807/182730]
Heart Team e malattie valvolari: L’importanza di un approccio multidisciplinare
Burzotta, Francesco;Romagnoli, Elisa;Aurigemma, Cristina;Bruno, Piergiorgio;Pavone, Natalia;Graziani, Francesca;Trani, Carlo;Crea, Filippo;Massetti, Massimo
2021
Abstract
Valvular heart diseases (VHD) are common in the elderly population and several therapeutic options are available to treat them. When selecting the management strategy for VHD patients, to evaluate the operatory risk, using special scores like STS score, EuroSCORE II and other more specific ones is pivotal. However, the risk scores do not consider some aspects, such as the clinical needs of the single patients, the management of local resources and the expertise of the center. The Heart Team, combining the experience of various specialists, can optimize the decision-making process through a better evaluation of the risk/benefit ratio of the therapeutic choices. The multidisciplinary discussion of the most complex cases is recommended by the international guidelines for the management of VHD and it is part of the clinical practice of many centers. So far, both trials and large clinical studies supporting such multidisciplinary management are lacking. Despite these important limitations, the Heart Team can be actually regarded as a promising tool to locally promote best practices for the treatment of VHD patients.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.